Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00388947 · ClinicalTrials.gov registry record
Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products
A clinical trial, sponsored by ASTORA Women's Health.
- Completed
- Registry status
- 1,543
- Enrollment target
NCT00388947: Completed study, sponsored by ASTORA Women's Health.
NCT00388947 is a clinical trial that has completed, run by ASTORA Women's Health. The registered enrollment target is 1,543 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00388947 has completed, sponsored by ASTORA Women's Health.
- COMPLETED
- Registry status
- 1,543 participants
- Enrollment target
Study Summary
This registry was observational (only collected information typically noted by the surgeon when their patients were routinely seen); there was no change to the care the patient received as a result of being part of the registry). Data collection focused on the surgical outcomes of AMS prolapse products.
Interventions
- DEVICE AMS Prolapse Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,543 participants |
| Start Date | 2006-09 |
| Est. Completion | 2010-05 |
What the finished NCT00388947 record still lists
NCT00388947 is an observational study that tracks outcomes without assigning an intervention. Its 1,543 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which AMS Prolapse Product is the first listed.
NCT00388947 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00388947 about?
NCT00388947 is a clinical study titled "Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products". This registry was observational (only collected information typically noted by the surgeon when their patients were routinely seen); there was no change to the care the patient received as a result of being part of the registry). Data collection focused on the surgical outcomes of AMS prolapse produ...
What is the current status of trial NCT00388947?
This trial is currently completed. The enrollment target is 1,543 participants. The study started on 2006-09. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00388947?
The interventions under investigation include: AMS Prolapse Product (DEVICE).
Who is sponsoring clinical trial NCT00388947?
This trial is sponsored by ASTORA Women's Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia